Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Some 20% to 30% of gout patients also have CKD, the researchers said, which is not surprising since they share many risk ...

Fish delivers protein, and when you choose a fatty fish like tuna, salmon or trout, you're also getting omega-3 fatty acids.

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular ...

Australia: In a recent case-case-time-control study of Australian residents hospitalized for hip fractures, the use of gabapentinoids (gabapentin and pregabalin) was linked to an increased risk of hip ...

Stress Hyperglycemia Ratio (SHR) was found to be a meaningful and valuable biomarker for predicting one-year mortality in ICU ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

At AHA 2024, the safety of GLP-1R agonists in heart failure and chronic kidney disease (CKD) patients was discussed.

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk ...

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

"This is the first study to show a clear benefit of GLP-1 receptor agonists on kidney failure or end-stage kidney disease, suggesting they have a key role in kidney-protective and heart-protective ...